Beyond current standards: combination therapy and emerging targets in diabetic kidney disease
{{output}}
Diabetic kidney disease continues to be a major contributor to kidney failure and is strongly associated with adverse cardiovascular outcomes. Even with routine use of renin-angiotensin system blockade, many patients show ongoing disease progression, indicatin... ...